Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Apr 24;61(5):e00208-17.
doi: 10.1128/AAC.00208-17. Print 2017 May.

Critical Need for Clarity in Polymyxin B Dosing

Nikolas J Onufrak  1 , Gauri G Rao  1 , Alan Forrest  1 , Jason M Pogue  2 , Marc H Scheetz  3   4 , Roger L Nation  5 , Jian Li  6 , Keith S Kaye  7
Affiliations
Comment

Critical Need for Clarity in Polymyxin B Dosing

Nikolas J Onufrak et al. Antimicrob Agents Chemother. .
No abstract available

Keywords: pharmacodynamics; pharmacokinetics; polymyxin B.

PubMed Disclaimer

Comment on

References

    1. Thamlikitkul V, Dubrovskaya Y, Manchandani P, Ngamprasertchai T, Boonyasiri A, Babic JT, Tam VH. 2017. Dosing and pharmacokinetics of polymyxin B in renal insufficiency. Antimicrob Agents Chemother 61:e01337-16. doi:10.1128/AAC.01337-16. - DOI - PMC - PubMed
    1. Zavascki AP, Goldani LZ, Cao G, Superti SV, Lutz L, Barth AL, Ramos F, Boniatti MM, Nation RL, Li J. 2008. Pharmacokinetics of intravenous polymyxin B in critically ill patients. Clin Infect Dis 47:1298–1304. doi:10.1086/592577. - DOI - PubMed
    1. Sandri AM, Landersdorfer CB, Jacob J, Boniatti MM, Dalarose MG, Falci DR, Behle TF, Bordinhao RC, Wang J, Forrest A, Nation RL, Li J, Zavascki AP. 2013. Population pharmacokinetics of intravenous polymyxin B in critically Ill patients: implications for selection of dosage regimens. Clin Infect Dis 57:524–531. doi:10.1093/cid/cit334. - DOI - PubMed
    1. Bedford Laboratories. 2011. Polymyxin B for injection. USP package insert. Bedford Laboratories, Bedford, OH.
    1. Nelson BC, Eiras DP, Gomez-Simmonds A, Loo AS, Satlin MJ, Jenkins SG, Whittier S, Calfee DP, Furuya Y, Kubin CJ. 2015. Clinical outcomes associated with polymyxin B dose in patients with bloodstream infections due to carbapenem-resistant Gram-negative rods. Antimicrob Agents Chemother 59:7000–7006. doi:10.1128/AAC.00844-15. - DOI - PMC - PubMed

LinkOut - more resources